Solara Active Pharma Sciences Limited (SOLARA.NS)
INR 725.65
(1.82%)
INR 725.65
(1.82%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 2.55 Billion INR | 7.93% |
| 2022 | 6.32 Billion INR | 14.96% |
| 2021 | 5.5 Billion INR | 4.62% |
| 2020 | 5.25 Billion INR | 15.03% |
| 2019 | 4.57 Billion INR | 7.7% |
| 2018 | 4.24 Billion INR | 850.59% |
| 2017 | 446.43 Million INR | -88.25% |
| 2016 | 3.79 Billion INR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 649.8 Million INR | -45.0% |
| 2024 Q2 | 1.39 Billion INR | -6.06% |
| 2023 Q4 | 1.18 Billion INR | -10.67% |
| 2023 FY | 6.82 Billion INR | 7.93% |
| 2023 Q1 | 1.67 Billion INR | 0.75% |
| 2023 Q2 | 1.76 Billion INR | 5.49% |
| 2023 Q3 | 1.32 Billion INR | -24.98% |
| 2022 Q2 | 1.5 Billion INR | 0.0% |
| 2022 Q4 | 1.65 Billion INR | -0.28% |
| 2022 FY | 6.32 Billion INR | 14.96% |
| 2022 Q1 | 1.5 Billion INR | 239.61% |
| 2022 Q3 | 1.66 Billion INR | 10.86% |
| 2021 Q2 | 1.71 Billion INR | 4.68% |
| 2021 FY | 5.5 Billion INR | 4.62% |
| 2021 Q1 | 1.63 Billion INR | 132.95% |
| 2021 Q4 | 441.8 Million INR | -74.23% |
| 2021 Q3 | 1.71 Billion INR | 0.26% |
| 2020 Q1 | 1.41 Billion INR | 246.68% |
| 2020 Q4 | 701.3 Million INR | -56.45% |
| 2020 FY | 5.25 Billion INR | 15.03% |
| 2020 Q2 | 1.53 Billion INR | 8.65% |
| 2020 Q3 | 1.61 Billion INR | 5.0% |
| 2019 Q4 | 407.2 Million INR | -71.26% |
| 2019 Q3 | 1.41 Billion INR | 3.41% |
| 2019 Q2 | 1.36 Billion INR | -0.49% |
| 2019 FY | 4.57 Billion INR | 7.7% |
| 2019 Q1 | 1.37 Billion INR | 500.6% |
| 2018 FY | 4.24 Billion INR | 850.59% |
| 2018 Q4 | 229.22 Million INR | -83.62% |
| 2018 Q3 | 1.39 Billion INR | 1.73% |
| 2018 Q2 | 1.37 Billion INR | 10.94% |
| 2018 Q1 | 1.23 Billion INR | -3.52% |
| 2017 Q2 | 73.38 Million INR | -93.15% |
| 2017 Q1 | 1.07 Billion INR | 0.0% |
| 2017 FY | 446.43 Million INR | -88.25% |
| 2017 Q4 | 1.28 Billion INR | 0.0% |
| 2016 FY | 3.79 Billion INR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Sigachi Industries Limited | 579.88 Million INR | -340.448% |
| Ind-Swift Limited | 946.56 Million INR | -169.828% |
| Bajaj HealthCare Limited | 985.34 Million INR | -159.209% |
| Sakar Healthcare Limited | 204.07 Million INR | -1151.525% |
| Aurobindo Pharma Limited | 55.65 Billion INR | 95.411% |
| Innova Captab Limited | 931.03 Million INR | -174.331% |
| Divi's Laboratories Limited | 14.17 Billion INR | 81.975% |
| AstraZeneca Pharma India Limited | 2.47 Billion INR | -3.259% |
| Morepen Laboratories Limited | 1.98 Billion INR | -28.511% |
| Mankind Pharma Limited | 29.27 Billion INR | 91.275% |
| Sequent Scientific Limited | 2.9 Billion INR | 11.983% |
| Wanbury Limited | 978.96 Million INR | -160.898% |
| Laurus Labs Limited | 11.9 Billion INR | 78.555% |
| Nectar Lifesciences Limited | 932.7 Million INR | -173.839% |
| Glenmark Life Sciences Limited | 11.64 Billion INR | 78.059% |
| Alembic Limited | 872.45 Million INR | -192.748% |
| Hikal Limited | 4.46 Billion INR | 42.782% |
| Alembic Pharmaceuticals Limited | 15.86 Billion INR | 83.906% |
| Neuland Laboratories Limited | 2.92 Billion INR | 12.822% |
| J. B. Chemicals & Pharmaceuticals Limited | 14.79 Billion INR | 82.734% |
| Glenmark Pharmaceuticals Limited | 46.95 Billion INR | 94.56% |
| IOL Chemicals and Pharmaceuticals Limited | 2.2 Billion INR | -16.043% |
| Themis Medicare Limited | 1.12 Billion INR | -126.87% |
| RPG Life Sciences Limited | 1.63 Billion INR | -56.166% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 97.96% |
| Lupin Limited | 125.09 Billion INR | 97.958% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -21.97% |
| Wockhardt Limited | 8.48 Billion INR | 69.881% |
| Vaishali Pharma Limited | 84.02 Million INR | -2939.546% |
| Aarti Pharmalabs Limited | 3.07 Billion INR | 16.924% |
| Jagsonpal Pharmaceuticals Limited | 438.55 Million INR | -482.397% |
| Jubilant Pharmova Limited | 14.45 Billion INR | 82.329% |
| FDC Limited | 3.49 Billion INR | 27.021% |
| Dr. Reddy's Laboratories Limited | 95.87 Billion INR | 97.336% |
| Kilitch Drugs (India) Limited | 412.42 Million INR | -519.285% |
| Eris Lifesciences Limited | 4.94 Billion INR | 48.328% |
| Venus Remedies Limited | 1.91 Billion INR | -33.284% |
| ZIM Laboratories Limited | 1.01 Billion INR | -152.118% |
| Bliss GVS Pharma Limited | 1.41 Billion INR | -79.965% |
| Par Drugs and Chemicals Limited | 58.28 Million INR | -4281.861% |
| Caplin Point Laboratories Limited | 2.17 Billion INR | -17.457% |
| Shilpa Medicare Limited | 3.33 Billion INR | 23.396% |
| Albert David Limited | 1.02 Billion INR | -148.902% |
| Ajanta Pharma Limited | 30.46 Billion INR | 91.616% |
| Hester Biosciences Limited | 908.84 Million INR | -181.029% |
| Suven Pharmaceuticals Limited | 1.4 Billion INR | -82.073% |
| Gufic Biosciences Limited | 1.18 Billion INR | -115.247% |
| Windlas Biotech Limited | 1 Billion INR | -153.758% |
| Procter & Gamble Health Limited | 2.99 Billion INR | 14.733% |
| Aarey Drugs & Pharmaceuticals Limited | 14.21 Million INR | -17870.168% |
| Mangalam Drugs & Organics Limited | 162.22 Million INR | -1474.389% |
| Granules India Limited | 10.31 Billion INR | 75.234% |
| Aarti Drugs Limited | 1.16 Billion INR | -118.771% |
| Bal Pharma Limited | 555.62 Million INR | -359.68% |
| Alkem Laboratories Limited | 32.83 Billion INR | 92.221% |
| Sun Pharmaceutical Industries Limited | 154.18 Billion INR | 98.343% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -137.771% |
| Medicamen Biotech Limited | 335.16 Million INR | -662.038% |
| Unichem Laboratories Limited | 6.72 Billion INR | 62.026% |
| Bafna Pharmaceuticals Limited | 455.58 Million INR | -460.62% |
| Biofil Chemicals and Pharmaceuticals Limited | 6.82 Million INR | -37350.147% |
| Valiant Laboratories Limited | 138.02 Million INR | -1750.408% |
| Orchid Pharma Limited | 800.77 Million INR | -218.955% |
| Medico Remedies Limited | 59.67 Million INR | -4180.017% |
| Ind-Swift Laboratories Limited | 2.12 Billion INR | -20.239% |
| Ipca Laboratories Limited | 18.98 Billion INR | 86.549% |
| Brooks Laboratories Limited | 51.18 Million INR | -4890.426% |
| Syncom Formulations (India) Limited | 345.63 Million INR | -638.963% |
| Piramal Enterprises Limited | 63.65 Billion INR | 95.987% |
| Torrent Pharmaceuticals Limited | 21.42 Billion INR | 88.077% |
| NATCO Pharma Limited | 10.05 Billion INR | 74.606% |
| Suven Life Sciences Limited | 109.75 Million INR | -2227.198% |
| Krebs Biochemicals & Industries Limited | 46.15 Million INR | -5433.625% |
| Strides Pharma Science Limited | 9.16 Billion INR | 72.124% |
| Indoco Remedies Limited | 12.06 Billion INR | 78.824% |
| Alpa Laboratories Limited | 127.38 Million INR | -1905.103% |
| Lasa Supergenerics Limited | 291.17 Million INR | -777.173% |
| Sun Pharma Advanced Research Company Limited | 3.07 Billion INR | 16.988% |